摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-[4-[2-(4-benzylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-dione | 480991-88-6

中文名称
——
中文别名
——
英文名称
6-[4-[2-(4-benzylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-dione
英文别名
——
6-[4-[2-(4-benzylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-dione化学式
CAS
480991-88-6
化学式
C27H29N5O4
mdl
——
分子量
487.558
InChiKey
QSNFHZZBWASQIR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    36
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    89.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    [4-(1,3-Dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)-phenoxy]-acetic acid ethyl ester1-苄基哌嗪sodium cyanide 作用下, 以40%的产率得到6-[4-[2-(4-benzylpiperazin-1-yl)-2-oxoethoxy]phenyl]-1,3-dimethyl-5H-pyrrolo[3,2-d]pyrimidine-2,4-dione
    参考文献:
    名称:
    1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor
    摘要:
    A large series of piperazin-, piperidin- and tetrahydroisoquinolinamides of 4-(1,3-dialkyl-9-deazaxanthin-8-yl)phenoxyacetic acid were prepared through conventional or multiple parallel syntheses and evaluated for their binding affinity at the recombinant human adenosine receptors, chiefly at the hA(2B) and hA(2A) receptor subtypes. Several ligands endowed with high binding affinity at hA(2B) receptors, excellent selectivity over hA(2A) and hA(3) and a significant, but lower, selectivity over hA(1) were identified. Among them, piperazinamide derivatives 23 and 52, and piperidinamide derivative 69 proved highly potent at hA2B (K-i = 11, 2 and 5.5 nM, respectively) and selective towards hA(2A) (hA(2A)/hA(2B) SI = 912, 159 and 630, respectively), hA(3) (hA(3)/hA(2B) SI = > 100, 3090 and >180, respectively) and hA(1) (hA(1)/hA(2B) SI = > 100, 44 and 120, respectively), SI being the selectivity index. A number of selected ligands tested in functional assays in vitro showed very interesting antagonist activities and efficacies at both A(2A) and A(2B) receptor subtypes, with pA(2) values close to the corresponding pK(i)s. Structure-affinity and structure-selectivity relationships suggested that the binding potency at the hA(2B) receptor may be increased by lipophilic substituents at the N4-position of piperazinamides and that an ortho-methoxy substituent at the 8-phenyl ring and alkyl groups at NI larger than the ones at N3, in the 9-deazaxanthine ring, may strongly enhance the hA(2A)/hA(2B) SI. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.01.002
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL ANTIVIRAL HELIOXANTHIN ANALOGS<br/>[FR] NOUVEAUX ANALOGUES ANTIVIRAUX DE L'HELIOXANTHINE
    申请人:UNIV YALE
    公开号:WO2005107742A1
    公开(公告)日:2005-11-17
    The present invention relates to novel antiviral helioxanthin analogs. These compounds may particularly be used alone or in combination with other drugs for the treatment of the following: hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus. In addition, compounds according to the present invention can be used to prevent or reduce the likelihood of the occurrence of tumors secondary to virus infection as well as other infections or disease states that are secondary to the virus infection.
    本发明涉及新型抗病毒螺旋木黄素类似物。这些化合物特别可单独使用或与其他药物结合治疗以下疾病:乙型肝炎病毒、黄病毒、疱疹病毒和人类免疫缺陷病毒。此外,根据本发明的化合物可用于预防或减少次生于病毒感染的肿瘤发生的可能性,以及其他次生于病毒感染的感染或疾病状态。
  • 6-Phenyldihydropyrrolopyrimidinedione derivatives
    申请人:Vidal Juan Bernat
    公开号:US20050070558A1
    公开(公告)日:2005-03-31
    6-phenylpyrrolopyrimidinedione derivatives of the formula (I), and pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 and R 5 are organic residues, L 1 is a spacer group and R 6 is C(O) NR 10 R 11 , —S(O) 2 NR 10 R 11 , ? —ON═CR 12 R 13 , or a heterocyclyl, aryl? or heteroaryl group, where R 10 , R 11 , R 12 and R 13 are organic residues, have therapeutic potential as A2 adenosine receptor inhibitors.
    式(I)的6-苯基吡咯嘧啶二酮衍生物及其药学上可接受的盐,其中R1、R2、R3、R4和R5均为有机残基,L1为间隔基,R6为C(O)NR10R11、—S(O)2NR10R11、?—ON═CR12R13或杂环基、芳基或杂芳基,其中R10、R11、R12和R13为有机残基,具有作为A2腺苷受体抑制剂的治疗潜力。
查看更多